Task-specific Training for Patients With Acute Exacerbation of COPD
COPD
1 other identifier
interventional
68
1 country
1
Brief Summary
Patients with Chronic Obstructive Pulmonary Disease (COPD) experience a progressive deterioration in their quality of life. Task-specific training is a type of approach focused on chronic patients that allows the acquisition of new skills or improvement of lost skills. The overall objective of this project is to evaluate the effectiveness of a task-specific training program during hospitalization of patients with acute exacerbation of COPD. A randomized clinical trial will be conducted in patients hospitalized for COPD. Participants after signing informed consent will be randomized between the control group (standard treatment) and the intervention group (task-specific training program in addition to standard treatment). The task-specific training program is a multidisciplinary program divided into three blocks where specific tasks will be performed on symptom education, education of activities of daily living and improvement of physical capacity with the aim of reinforcing skills necessary for the self-management of COPD patients in the short, medium and long term.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 12, 2024
CompletedStudy Start
First participant enrolled
January 15, 2024
CompletedFirst Posted
Study publicly available on registry
January 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2024
CompletedJanuary 25, 2024
January 1, 2024
6 months
January 12, 2024
January 24, 2024
Conditions
Outcome Measures
Primary Outcomes (5)
Modified Borg Scale
the perceived dyspnoea is measure with the Borg Scale. This scale range from 0-10 where higher value indicate worse state, more dyspnoea.
Baseline, hospital discharge, 1 month, 3 months and 6 months
COPD Assessment Test (CAT)
It consists of eight questions covering cough, phlegm, chest tightness, breathlessness, activity limitations at home, confidence leaving home, sleep and energy. The items are graded from 0 to 5, giving a total score range from 0 to 40, where lower scores indicate fewer symptoms and a better quality of life.
Baseline, hospital discharge, 1 month, 3 months and 6 months
EuroQol-5D (EQ-5D)
Changes in quality of life were measured using the Euroqol 5dimensions which comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. It also includes a visual analogue scale to report the health status from 0 to 100. Higher score indicate higher quality of life. Better.
Baseline, hospital discharge, 1 month, 3 months and 6 months
Chronic Obstructive Pulmonary Disease Knowledge Questionnaire (COPD-Q)
Evaluated at baseline by Chronic Obstructive Pulmonary Disease Questionnaire (COPD-Q). COPD knowledge was evaluated using the Chronic Obstructive Pulmonary Disease Knowledge Questionnaire (COPD-Q; Maples, Franks, Ray, Stevens, \& Wallace, 2010). The COPD-Q is a valid, readable, and reliable 13-item (each one score 0 to 3) self-administered true/false questionnaire assessing COPD knowledge in patients with low health literacy skills. A higher punctuation indicates better results.
Baseline, 1 months and 6 months
Test of Adherence to Inhalers (TAI)
This questionnaire has two forms, the first type being a 10-item to identify the patient's adherence status to inhalers. There are 2 other questions to check the degree of compliance. The 10-item form is scored from 1 (the poorest) to 5(the best) for each item, and the total score of the questionnaire ranges from 10 to 50 (a score of 45 or less indicates poor adherence, 46 to 49 is intermediate adherence, and 50 indicates good adherence
Baseline, hospital discharge, 1 month, 3 months and 6 months
Secondary Outcomes (7)
Forced expiratory volume in the first second (FEV1)
Baseline and hospital discharge
Pressure expiratory force (PEF)
Baseline and hospital discharge
Pressure inspiratory force (PIF)
Baseline and hospital discharge
Technique of the inhaler
Baseline and hospital discharge
Postural evaluation
Baseline and hospital discharge
- +2 more secondary outcomes
Study Arms (2)
Task-specific training
EXPERIMENTALUsual care
OTHERInterventions
Participants in the intervention group will receive the treatment established for the control group and nursing care based on task-specific training. The intervention was designed with the aim of improving inhaler management in COPD patients. The content of the tasks will be adapted to the different types of devices present in the patient's therapeutic regimen, mainly pressurized cartridge and dry powder devices. In order to carry out the intervention, several tasks related to education, assessment and/or training will be established with the aim of improving the ability to use the prescribed inhalers. The tasks have been classified into 3 blocks: technique execution, device cleaning and medication administration.
All patients will receive standard treatment during their hospital stay (medical and pharmacological care). This treatment will include steroids, antibiotics, inhaled bronchodilators and oxygen therapy. In addition, during hospitalization they may receive diuretics, anticoagulants and cardiovascular treatments if necessary.
Eligibility Criteria
You may qualify if:
- Patients hospitalized for acute exacerbation of COPD.
- Over 18 years of age.
- Who wish to participate in the study.
- Who sign the informed consent form.
You may not qualify if:
- Patients with inability to provide informed consent.
- Presence of psychiatric or cognitive disorders, organ failure, cancer and/or inability to cooperate.
- Patients who had experienced exacerbation of COPD in the previous month were also excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Health Sciences. University of Granada.
Granada, Granada, 18071, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Marie Carmen Valenza, Chair
Universidad de Granada
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chair of Physiotherapy
Study Record Dates
First Submitted
January 12, 2024
First Posted
January 25, 2024
Study Start
January 15, 2024
Primary Completion
July 15, 2024
Study Completion
August 15, 2024
Last Updated
January 25, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share